ATE347546T1 - Hydroxyformamidin-derivate und diese enthaltende medikamente - Google Patents

Hydroxyformamidin-derivate und diese enthaltende medikamente

Info

Publication number
ATE347546T1
ATE347546T1 AT01941061T AT01941061T ATE347546T1 AT E347546 T1 ATE347546 T1 AT E347546T1 AT 01941061 T AT01941061 T AT 01941061T AT 01941061 T AT01941061 T AT 01941061T AT E347546 T1 ATE347546 T1 AT E347546T1
Authority
AT
Austria
Prior art keywords
group
formula
substituted
represented
participates
Prior art date
Application number
AT01941061T
Other languages
English (en)
Inventor
Masakazu Sato
Noriyuki Miyata
Takaaki Ishii
Yuko Kobayashi
Hideaki Amada
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE347546T1 publication Critical patent/ATE347546T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT01941061T 2000-06-15 2001-06-15 Hydroxyformamidin-derivate und diese enthaltende medikamente ATE347546T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2000180477 2000-06-15
JP2000180479 2000-06-15
JP2000336140 2000-11-02
JP2000359781 2000-11-27

Publications (1)

Publication Number Publication Date
ATE347546T1 true ATE347546T1 (de) 2006-12-15

Family

ID=27481364

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01941061T ATE347546T1 (de) 2000-06-15 2001-06-15 Hydroxyformamidin-derivate und diese enthaltende medikamente

Country Status (12)

Country Link
US (1) US6670382B2 (de)
EP (1) EP1291343B1 (de)
JP (1) JP4904659B2 (de)
KR (1) KR100776095B1 (de)
CN (1) CN1177824C (de)
AT (1) ATE347546T1 (de)
AU (2) AU2001274535B2 (de)
CA (1) CA2411418C (de)
DE (1) DE60125036T2 (de)
DK (1) DK1291343T3 (de)
ES (1) ES2280379T3 (de)
WO (1) WO2001096309A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001274535B2 (en) 2000-06-15 2005-06-30 Taisho Pharmaceutical Co., Ltd. Hydroxyformamidine derivatives and medicines containing the same
US7214714B2 (en) 2001-04-26 2007-05-08 Taisho Pharmaceutical Co. Ltd. 20-hydroxyeicosatetraenoic acid production inhibitors
WO2002089408A1 (en) * 2001-05-02 2002-11-07 Symbian Limited Group communication method for a wireless communication device
JPWO2003022821A1 (ja) * 2001-09-06 2004-12-24 大正製薬株式会社 20−hete産生酵素阻害作用を有するヘテロ環誘導体
AU2003262069A1 (en) 2002-09-12 2004-04-30 Taisho Pharmaceutical Co., Ltd. N-hydroxyformamidine derivative
ES2765632T3 (es) 2005-07-29 2020-06-10 Bayer Cropscience Lp Estabilización de productos para el cuidado del cuerpo y del hogar contra la degradación por radiación UV utilizando derivados de merocianina
RU2532135C2 (ru) * 2007-02-22 2014-10-27 Зингента Партисипейшнс Аг Производные иминопиридина и их применение в качестве микробиоцидов
BR112018015760A2 (pt) * 2016-02-15 2019-01-02 Taisho Pharmaceutical Co., Ltd. composto de piridina substituído por azol

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959368A (en) 1975-04-28 1976-05-25 Stauffer Chemical Company N,N-dimethyl-N'-phenylthiocarbamyl formamidine and its use as an anti-inflammatory agent
US3998970A (en) * 1975-04-28 1976-12-21 Stauffer Chemical Company N,N-dimethyl-N'-phenylthiocarbamyl formamidine and its use as an anti-inflammatory agent
GB1594261A (en) 1977-02-18 1981-07-30 Shell Int Research Benzyloxime ethers
US4079149A (en) 1977-06-30 1978-03-14 Shell Oil Company Benzyl oxime ethers
IL56878A (en) 1978-03-31 1984-03-30 Rhone Poulenc Inc Ketoximinoethers and their use as insecticides
US4158015A (en) 1978-08-16 1979-06-12 Mobil Oil Corporation Process for the stereoselective synthesis of the E isomer of aryl alkyl oximes
DE2907972A1 (de) 1979-03-01 1980-09-11 Bayer Ag Omega -halogen-acetophenon-oximether, verfahren zu ihrer herstellung sowie ihre verwendung als zwischenprodukte zur herstellung von omega -azolyl-acetophenon-oximethern
AU6159680A (en) 1979-08-24 1981-04-09 Rhone-Poulenc, Inc. Ketoximinoether insecticides
DE3005899A1 (de) 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Derivate des 1,2,4-triazols und imidazols, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel
DE3044564A1 (de) 1980-11-26 1982-07-15 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von (alpha)-bromacetophenonoximethern
US4474815A (en) 1981-04-30 1984-10-02 Commonwealth Scientific And Industrial Research Organization Insecticidal oximes
US4566901A (en) 1982-05-06 1986-01-28 Ciba-Geigy Corporation Novel oxime ethers, the preparation thereof, compositions containing them and the use thereof
US4434182A (en) 1982-11-01 1984-02-28 Fmc Corporation Insecticidal substituted-biphenylmethyl oxime ethers
IL75858A (en) 1984-07-31 1989-02-28 Commw Scient Ind Res Org Substituted benzyl ethers of oximes,their production and their use as arthropodicides
US4824476A (en) 1985-06-24 1989-04-25 Ciba-Geigy Corporation Herbicidally active derivatives of N-phenyl-3,4,5,6-tetrahydrophthalimide
DE4213149A1 (de) 1992-04-22 1993-10-28 Hoechst Ag Akarizide, insektizide und nematizide substituierte (Hetero)-Aryl-Alkyl-ketonoxim-O-ether, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
US5267857A (en) 1993-02-12 1993-12-07 A-Dec, Inc. Brightness control system for dental handpiece light
ES2256053T3 (es) * 1999-11-01 2006-07-16 Taisho Pharmaceutical Co., Ltd Inhibidor de la enzima de produccion de 20-hete.
AU2001274535B2 (en) 2000-06-15 2005-06-30 Taisho Pharmaceutical Co., Ltd. Hydroxyformamidine derivatives and medicines containing the same
US7214714B2 (en) * 2001-04-26 2007-05-08 Taisho Pharmaceutical Co. Ltd. 20-hydroxyeicosatetraenoic acid production inhibitors

Also Published As

Publication number Publication date
US20030186979A1 (en) 2003-10-02
EP1291343B1 (de) 2006-12-06
DK1291343T3 (da) 2007-02-05
KR20030010690A (ko) 2003-02-05
CA2411418A1 (en) 2002-12-06
AU2001274535B2 (en) 2005-06-30
JP4904659B2 (ja) 2012-03-28
EP1291343A4 (de) 2004-04-07
WO2001096309A1 (en) 2001-12-20
ES2280379T3 (es) 2007-09-16
CN1436173A (zh) 2003-08-13
DE60125036D1 (de) 2007-01-18
DE60125036T2 (de) 2007-06-21
US6670382B2 (en) 2003-12-30
HK1057043A1 (en) 2004-03-12
CA2411418C (en) 2010-01-12
AU7453501A (en) 2001-12-24
EP1291343A1 (de) 2003-03-12
KR100776095B1 (ko) 2007-11-15
CN1177824C (zh) 2004-12-01

Similar Documents

Publication Publication Date Title
EA200900358A1 (ru) Энантиомерно чистые фосфоиндолы в качестве ингибиторов hiv
ATE288443T1 (de) Neue pyrazin-derivate oder salze davon, pharmazeutische zusammensetzungen, die die derivate oder deren salze enthalten und intermediate zu beider herstellung
EP1489077A4 (de) 2- furancarbonsäurehydrazide und diese enthaltende pharmazeutische zusammensetzung
BRPI9908319B8 (pt) composto amino cíclico, composição farmacêutica, medicamento contendo um composto amino cíclico ou um sal farmacologicamente aceitável do mesmo, e, uso de um composto amino cíclico ou um sal farmacologicamente aceitável do mesmo.
MXPA02012034A (es) Derivados de tiofeno utiles como agentes anticancerosos.
NO884202D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzimidazolin-2-okso-1-karboksylsyrederivater.
KR890012649A (ko) 아릴아미도(및 아릴티오아미도)-아자비사이클로 알칸으로 기억력을 향상시키거나 기억력 부족을 교정시키는 방법
IT1228293B (it) Benzoderivati di composti eterociclici contenenti azoto.
DE60125036D1 (de) Hydroxyformamidin-derivate und diese enthaltende medikamente
DE60137442D1 (de) 5-amidino-2-hydroxybenzolsulfonamidderivate, pharmazeutischen zusammensetzungen, die diese verbindungen enthalten, und zwischenprodukte zu deren herstellung
ATE476431T1 (de) Piperidin- und azetidinderivate als glyt1- inhibitoren
DE69910083D1 (de) Katecholhydrazon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten
ATE181918T1 (de) Purinderivate und ihre pharmazeutisch akzeptablen salze
AU759604B2 (en) Inhibitor for 20-hete-yielding enzyme
DE60119378T8 (de) Benzofuranderivate und pharmazeutische zusammensetzungen, die diese enthalten
ATE215075T1 (de) Hydroxylamin-derivate mit anti-ischämischer wirkung und pharmazeutische zusammensetzungen diese enthaltend
AR046132A1 (es) Composicin farmaceutica que contiene al menos un compuesto con actividad de receptor de cb1, o un profarmaco , tautomero o sal del mismo, como componente activo adecuado para el tratamiento y/o profilaxis de enfermedades relacionadas con el receptor cb1 en pacientes juveniles y/o para el tratamiento
ATE66232T1 (de) Pyrimido(5,4-b>(1,4>oxazinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel sowie zwischenprodukte darstellende pyrimido(5,4-b>(1,4>oxazinderivate.
TH91789A (th) อนุพันธ์เฟนิล-1,2,4-ออกซะไดแอโซโลนที่มีหมู่เฟนิล, กรรมวิธีสำหรับการเตรียมสารเหล่านี้และการใช้สารเหล่านี้ทางเภสัชกรรม
TH84545A (th) สารรักษาโรค
TH62262A (th) สารต้านแบคทีเรีย
TH68183A (th) อนุพันธ์ไซโคลแอลคิล ที่มีหมู่ไบโอไอโซสเทอริค คาร์บอกซิลิคแอซิด, กรรมวิธีสำหรับเตรียมสารเหล่านี้และการใช้สารเหล่านี้เป็นยารักษาโรค
IS7333A (is) MMP tálmar
TH65335A (th) สารประกอบพรัยโรโล [2,3d] ไพริมิดิน
TH84547A (th) สารรักษาโรค

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1291343

Country of ref document: EP